BIO KEY INTERNATIONAL INC BKYI revenue by segment, product and geography
In its fiscal year ending 2025-12-31, BIO KEY INTERNATIONAL INC reported revenue across 3 products and services; the largest, License, was $3.42M, 57.7% of the filed sum (-34.0% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- License$3.42M57.7%-34.0% yoy
- Hardware$1.34M22.6%+112.5% yoy
- Service$1.17M19.7%+5.7% yoy
Members sum to the consolidated $5.94M for this period.
- North America$2.67M45.0%-22.9% yoy
- EMESA$2.25M37.9%+30.9% yoy
- Africa$782K13.2%-52.7% yoy
- Asia$232K3.9%+154.4% yoy
Members sum to the consolidated $5.94M for this period.
- License$1.37M63.7%+24.3% yoy
- Hardware$531K24.8%+125.3% yoy
- Service$248K11.6%-8.9% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.